Senior Account Manager, San Diego at Schrödinger

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s degree or higher in Chemistry, Biology, or a related scientific discipline
An understanding of the drug discovery process
Minimum five years experience selling complex scientific software solutions, and a track record of exceeding targets
Self-motivated sales professional with a proven track record of exceeding targets
Effective communicator capable of explaining complex scientific and technical solutions in clear, compelling ways
Creative problem-solver who understands customer needs and tailors solutions to deliver value
Strategic thinker who enjoys developing account plans and managing complex sales processes
Skilled negotiator who excels with value-based selling and closing high-impact deals
Collaborative contributor, adept at working with cross-functional teams

Responsibilities

Create and implement effective strategies to increase revenue in your territory and ensure business objectives are met
Manage all engagements with assigned accounts, including coordination with cross-functional teams
Identify and close new software and services opportunities in your territory
Develop and maintain relationships with key stakeholders at your accounts
Provide client feedback and market insights to internal product managers and scientific support team members
Maintain accurate sales forecast reporting and client activity tracking in Salesforce

Skills

Salesforce

Drug Discovery

Account Management

Territory Management

Value-Based Selling

Sales Forecasting

Stakeholder Management

Scientific Software Sales

Cross-Functional Collaboration

Negotiation

Schrödinger

Computational platform for biopharmaceutical research

About Schrödinger

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by using sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative research and drug discovery programs, allowing for a more integrated approach to scientific research. The company's goal is to enhance scientific research and development through its platform, ultimately leading to the discovery of new drugs and therapies.

New York City, New YorkHeadquarters

1990Year Founded

$362.7MTotal Funding

IPOCompany Stage

Government & Public Sector, Enterprise Software, BiotechnologyIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Parental Leave

Risks

Recursion and Exscientia merger creates strong AI-driven drug discovery competitor.

Avicenna's independent expansion could lead to competitive tensions with Schrödinger.

High R&D costs may strain resources despite Gates Foundation's $10M grant.

Differentiation

Schrödinger's platform supports diverse clients, including biopharma, academia, and government labs.

The company excels in rapid drug discovery, exemplified by SGR-1505's swift development.

Schrödinger's collaboration with Avicenna enhances medicinal chemistry through machine learning.

Upsides

$19.5M Gates Foundation grant boosts platform for neglected diseases, expanding market reach.

Predictive toxicology tools initiative could lead to safer, efficient drug development.

SGR-1505 discovery showcases ability to reduce drug discovery timelines significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free